Filing Flows

Filing Flows › DataMeds AI (MEDS) › Who owns the stock

Who owns DataMeds AI (MEDS) stock

10 funds reported DataMeds AI (MEDS) shares in their latest 13F filings, worth $159K in all. The largest holder is Jane Street Group, LLC ($64K). Last quarter 9 funds added to their stakes and 0 cut them.

Largest holders of MEDS (13F)Largest holders of MEDS (13F)Jane Street Group, LLC$64KGeode Capital Management, LLC$39KVanguard Capital Management LLC$34KVanguard Fiduciary Trust$19KTower Research Capital LLC$2KBarclays$384Fortitude Family Office, LLC$374Farther Finance Advisors, LLC$63Global Retirement Partners, LLC$6Danske Bank A/S$3

Largest holders (13F)

FundSharesValueChangeQuarter
Jane Street Group, LLC20,532$64Knew2026-06-30
Geode Capital Management, LLC12,467$39Knew2026-06-30
Vanguard Capital Management LLC11,085$34Knew2026-06-30
Vanguard Fiduciary Trust6,191$19Knew2026-06-30
Tower Research Capital LLC678$2Knew2026-06-30
Barclays121$384decrease2026-09-30
Fortitude Family Office, LLC118$374unchanged2026-09-30
Farther Finance Advisors, LLC20$63new2026-09-30
Global Retirement Partners, LLC2$6new2026-06-30
Danske Bank A/S1$3new2026-06-30

DataMeds AI's latest quarter

DataMeds AI, Q2 2026: revenue $1.8M (-77% year over year), operating margin -412.7%, net loss $18.4M, operating cash flow −$2.9M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most MEDS stock?

By the latest 13F filings: Jane Street Group, LLC ($64K); Geode Capital Management, LLC ($39K); Vanguard Capital Management LLC ($34K); Vanguard Fiduciary Trust ($19K); Tower Research Capital LLC ($2K).

What is the short interest in MEDS?

476,294 shares were sold short at the 2026-10-15 settlement, -9.29% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.